New Drug Prevents Migraines Before They Start

Wochit - May 18, 2018
The FDA approved a new migraine drug on Thursday.

Aimovig, known generically as erenumab, is the first drug shown to stop migraine headaches before they start.

The drug would be approved for patients who have tried other drugs and found no relief.

In studies, it did not entirely prevent migraines, but reduced their frequency.

FDA's approval means the drug may soon be available under prescription. It should also be paid for by health insurance. The drug's maker, Amgen, said U.S.

list price is for the once monthly self-injection treatment will be $575 per month or $6,900 annually..


Recent related news

Shares of Ocular Therapeutix Inc. (NASDAQ:OCUL) climbed Thursday after the drug maker announced that the US Food and Drug Administration (FDA) had accepted its...
3 days ago • Proactive Investors

Shares in Mersana Therapeutics (NASDAQ:MRSN) plunged Thursday after the biopharma group reported that the US Food and Drug Administration has partially halted a...
3 days ago • Proactive Investors

Recent related videos

CBS Dallas Digital -   β–Ά  00:53

Bloomberg Global Business -   β–Ά  07:35

WDAF -   β–Ά  01:51

You might like